Cor Vasa 2024, 66(1):23-28 | DOI: 10.33678/cor.2023.095
Compliance of patients with atrial fibrillation using new oral anticoagulants - results survey
- a Department of Health Sciences, Faculty of Medicine, Masaryk University, Brno, the Czech Republic
- b Department of Public Health, Faculty of Medicine, Masaryk University, Brno, the Czech Republic
- c Institute of Health Information and Statistics of the Czech Republic, Prague, the Czech Republic
- d 1st Department of Neurology, Faculty of Medicine, Masaryk University, Brno, the Czech Republic
- e Olomouc University Hospital, Olomouc, the Czech Republic
Introduction: Continuous medication use is essential for patients with atrial fibrillation using new oral anticoagulants. Older age and polymorbidity may affect compliance related to the anticoagulation therapy.
Methods: An observational cohort study (STROBE) assessed patients' compliance with selected cardiovascular diagnoses and other comorbidities who received NOAC and outpatient care in specialized clinics in the Czech Republic in the questionnaire survey between April and May 2023.
Results: Patients meeting the study criteria were approached by the treating physician for inclusion (4 cardiology and 1 neurology clinic). A total of 274 patients (146 women, 128 men) with a primary diagnosis of atrial fibrillation and at least one confirmed secondary diagnosis of heart attack, cerebral infarction, transient cerebral ischemic attack (TIA), obesity, arterial hypertension, or diabetes mellitus participated. Statistical analysis confirmed that patients with a history of stroke or TIA had a higher number of regular follow-up visits (once every three months) (p = 0.002492). Furthermore, data analysis demonstrated that patients who had been on treatment for a shorter time tended to have more frequent regular follow-up visits (treatment duration up to 3 months/average check-ups 1.7 times; 3-5 months/0.9 times; 6-12 months/0.7 times). In one patient (55 years) with paroxysmal atrial fibrillation and a diagnosis of TIA, who declared irregularity of NOAC use for 3-5 months of treatment, a relapse of TIA was identified.
Conclusion: A high burden of additional comorbidities was identified in the observed sample, along with the inadequate declaration of the regularity of NOAC medication use and the resulting risks. Appropriate patient education is essential, especially among older patients at a high risk of stroke, considering the in- creasing prescription rates.
Keywords: Atrial fibrillation, Compliance, New oral anticoagulants, Risk, Stroke
Received: December 4, 2023; Revised: December 4, 2023; Accepted: December 15, 2023; Prepublished online: June 2, 2012; Published: March 5, 2024 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg 2016;50:e1-e88.
Go to original source...
Go to PubMed...
- Mc Namara K, Alzubaidi H, Jackson JK. Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?. Integr Pharm Res Pract 2019;8:1-11.
Go to original source...
Go to PubMed...
- Hayashi M, Shimizu W, Albert CM. The spectrum of epidemiology underlying sudden cardiac death. Circ Res 2015;116:1887-1906.
Go to original source...
Go to PubMed...
- Sposato LA, Cerasuolo JO, Cipriano LE, et al. Atrial fibrillation detected after stroke is related to a low risk of ischemic stroke recurrence. Neurology 2018;90:e924-e931.
Go to original source...
Go to PubMed...
- Sposato LA, Chaturvedi S, Hsieh CY, et al. Atrial Fibrillation Detected After Stroke and Transient Ischemic Attack: A Novel Clinical Concept Challenging Current Views. Stroke 2022;53:e94-e103.
Go to original source...
Go to PubMed...
- Marzec LN, Wang J, Shah ND, et al. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation. J Am Coll Cardiol 2017;69:2475-2484.
Go to original source...
Go to PubMed...
- Fischer U, Koga M, Strbian D, et al. Early versus Later Anticoagulation for Stroke with Atrial Fibrillation. N Engl J Med 2023;388:2411-2421.
Go to original source...
Go to PubMed...
- Ko D, Lin KJ, Bessette LG, et al. Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020. JAMA Netw Open 2022;5:e2242964.
Go to original source...
Go to PubMed...
- Kupó P, Szakács Z, Solymár M, et al. Direct Anticoagulants and Risk of Myocardial Infarction, a Multiple Treatment Network Meta-Analysis. Angiology 2020;71:27-37.
Go to original source...
Go to PubMed...
- Vranckx P, Valgimigli M, Heidbuchel H. The Significance of Drug-Drug and Drug-Food Interactions of Oral Anticoagulation. Arrhythm Electrophysiol Rev 2018;7:55-61.
Go to original source...
Go to PubMed...
- Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014;383:955-962.
Go to original source...
Go to PubMed...
- Táborský M, Tomek A, Čihák R, et al. Cost-effectiveness analysis of first-line NOAC prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Cor Vasa 2019;61:e354-e369.
Go to original source...
- Fiala M, Haman L, Čihák R. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation. Summary of the document prepared by the Czech Society of Cardiology. Cor Vasa 2021;63:135-161.
Go to original source...
- Pokorney SD, Bloom D, Granger CB, et al. Exploring patient-provider decision-making for use of anticoagulation for stroke prevention in atrial fibrillation: Results of the INFORM-AF study. Eur J Cardiovasc Nurs 2019;18:280-288.
Go to original source...
Go to PubMed...
- Holthuis E, Smits E, Spentzouris G, et al. Increased Risk of Stroke Due to Non-adherence and Non-persistence with Direct Oral Anticoagulants (DOACs): Real-World Analyses Using a Nested Case-Control Study from The Netherlands, Italy and Germany. Drugs Real World Outcomes 2022;9:597-607.
Go to original source...
Go to PubMed...
- Garcia C, Silva M, Araújo M, et al. Admission Severity of Atrial-Fibrillation-Related Acute Ischemic Stroke in Patients under Anticoagulation Treatment: A Systematic Review and Meta- -Analysis. J Clin Med 2022;11:3563.
Go to original source...
Go to PubMed...
- Akagi Y, Iketaki A, Nakamura R, et al. Association between Cerebral Infarction Risk and Medication Adherence in Atrial Fibrillation Patients Taking Direct Oral Anticoagulants. Healthcare (Basel) 2021;9:1313.
Go to original source...
Go to PubMed...
- Serrao A, Lucani B, Assanto Manfredi G, et al. Satisfaction, quality of life and therapy adherence assessment in real life patients transitioning from vitamin K antagonists to direct oral anticoagulants. J Thromb Thrombolysis 2020;50:718-723.
Go to original source...
Go to PubMed...
- Garkina SV, Vavilova TV, Lebedev DS, et al. Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants. J Geriatr Cardiol 2016;13:807-810.
- Táborský M, Kautzner J, Fedorco M, et al. 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. Translation of the document prepared by the Czech Society of Cardiology. Cor Vasa 2023;65(Suppl. 1):23-75.
Go to original source...
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.